Yves Leurquin | Head of Vaccine Market Access
Takeda Pharmaceuticals International Ag

Yves Leurquin, Head of Vaccine Market Access, Takeda Pharmaceuticals International Ag

Head Vaccine Market Access - Development of Takeda’s commercial vaccine strategy,
- Commercial input to portfolio management and business development decisions,
- Company representation to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).


Day Two 11th October, Human @ 09:10

Plenary discussion: Where is the global vaccine industry shifting to for new collaborations? Perspectives from emerging markets and Asia

  • The role of emerging markets in the global supply and demand for vaccines
  • What vaccine technologies and vaccine candidates are favourable?
  • Does it align with other philanthropy organisations?
  • The role of Public-Public Partnerships (P2Ps) in vaccine R&D for poverty related and neglected diseases (PRNDs)
  • Priorities for linking new vaccine development with public health in low and middle income countries

back to speakers